PowerUp Acquisition Corp. *

PowerUp Acquisition Corp. *

Dec 30, 2021 by Anthony Sozzi

PROPOSED BUSINESS COMBINATION: Aspire Biopharma, Inc

ENTERPRISE VALUE: $tbd million
ANTICIPATED SYMBOL: tbd

PowerUp Acquisition Corp. proposes to combine with Aspire Biopharma, Inc.

Aspire Biopharma has developed a disruptive technology through a Novel Soluble Formulation that addresses emergencies, drug efficacy, dosage management, and response time.


SUBSEQUENT EVENT – 12/26/24 – LINK

Subscription Agreement

  • On December 13, 2024, PowerUp Acquisition Corp. (PUAC) entered into an agreement with Blackstone Capital Advisors, Inc. (Blackstone) to provide funding for PUAC’s expenses in connection with its proposed Business Combination with Aspire Biopharma.
    • Blackstone agreed to provide PUAC with up to $500,000 in funding, with an original issue discount of 20%, meaning the effective amount loaned could be lower than the nominal amount.
    • As of December 19, 2024, Blackstone has provided $184,543.80.
    • The loan will be repaid upon the earlier of June 1, 2025, or the date PUAC raises at least $5,000,000 in gross proceeds through an offering of its debt or equity securities.
    • In return for the funding, PUAC will issue to Blackstone 3 Class A ordinary shares of PUAC for each dollar loaned.
    • The loan bears interest at an annual rate of 10%, and an additional exit fee of 10% of the principal and accrued interest will be paid upon maturity.
    • PUAC also agreed to register the Class A ordinary shares issued to Blackstone with the SEC under a registration rights agreement.
    • In the event of specific defaults or if the Business Combination is not completed, additional provisions and conditions may apply.

TRANSACTION

  • The company has an aggregate value equal to:
    • (a) $316.8 million less
    • (b) the amount by which Aspire’s cash at Closing is less than the Minimum Cash Condition (but only in the event PowerUp waives the Minimum Cash Condition), if any, less
    • (c) Aspire’s Indebtedness at Closing.

SPAC FUNDING

  • No additional funding was disclosed at this time.

LOCK-UP

  • Company and Sponsor
    • Six months from the Closing or if the share price equals or exceeds $12.00 for any 20/30 trading days at least 150 days after the Closing.

NOTABLE CONDITIONS TO CLOSING

  • The minimum cash closing condition is $0.00.

NOTABLE CONDITIONS TO TERMINATION

  • By either PowerUp and Aspire if any of the conditions to Closing have not been satisfied or waived by August 17, 2025 (the “Outside Date”)

ADVISORS

  • Company
    • Sichenzia Ross Ference Carmel LLP serves as legal counsel.
  • SPAC
    • Dykema Gossett, PLLC serves as legal counsel.

LETTER OF INTENT – 7/31/24 – LINK

  • The SPAC signed a letter of intent with Aspire Biopharma, Inc.
    • Aspire Biopharma, Inc. is a privately held, early-stage biopharmaceutical technology company founded in 2021. The Company is engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for “do no harm” FDA-approved drugs, nutraceuticals, and supplements. Aspire has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, patient compliance and safety, and rapid response and absorption time when required and desired.
  • Advisors
    • Dykema Gossett, PLLC serves as legal counsel to PowerUp Acquisition Corp.
    • Sichenzia Ross Ference Carmel LLP serves as legal counsel to Aspire BioPharma, Inc.

The below-announced combination was terminated on 7/23/24.  It will remain on the page for reference purposes only. Once a new combination is announced it will be added to the top of the page.


PROPOSED BUSINESS COMBINATION: Visiox Holdings, Inc [Terminated]

ENTERPRISE VALUE: $TBD million
ANTICIPATED SYMBOL: VSXP

PowerUp Acquisition Corp. proposes to combine with Visiox Holdings, Inc.

Visiox Pharma is a privately funded biopharmaceutical company specializing in the development and commercialization of ophthalmic therapeutic candidates. Their primary focus is on addressing highly prevalent eye diseases that currently have limited treatment options. The company aims to disrupt and revolutionize the current market to maximize patient and physician satisfaction through close collaboration with eye care professionals.


SUBSEQUENT EVENT – 6/7/24 – LINK

  • The SPAC reduced the minimum cash condition from $5,000,000 to $1.00.
  • The Outside Date was extended until June 30, 2024.

EXTENSION – 5/28/24 – LINK

  • The SPAC approved the extension from May 23, 2024 to February 17, 2024.
    • 1,226,085 shares were redeemed at the meeting.
    • No contribution will be made into the trust account.

SUBSEQUENT EVENT – 5/22/24 – LINK

  • The SPAC entered into a non-redemption agreement with several unaffiliated third parties in exchange for them agreeing not to redeem an aggregate of 150,000 shares
    • The Sponsor will transfer 25,000 Class B shares to the non-redeeming shareholders

SUBSEQUENT EVENT – 5/20/24 – LINK

  • The SPAC entered into a non-redemption agreement with several unaffiliated third parties in exchange for them agreeing not to redeem an aggregate of 150,000 shares
    • The Sponsor will transfer 50,000 Class B shares to the non-redeeming shareholders

TRANSACTION

  • The value of these shares equals the Merger Consideration, which is calculated as $80 million minus any shortfall in Net Working Capital, Company Transaction Expenses, Company Indebtedness at Closing, and the product of the number of Rollover RSUs times $10.00.
    • Additionally, Visiox’s security holders and the Sponsor will have the right to receive, collectively, an extra 6,000,000 shares of PowerUp Common Stock under specific contingent conditions.
  • The business combination is expected to close in the first quarter of 2024, and upon closing the combined company will be named Visiox Holdings, Inc. with its common stock and warrants expected to be listed on Nasdaq under the ticker symbols VSXP and VSXPW, respectively.

SPAC FUNDING

  • There is no additional funding at this time.

EARNOUT

  • Company and Sponsor
    • Each will receive 3 million shares subject to earnout conditions, 6 million shares total
      • 1 million shares each if Omlonti’s first commercial sale occurs within 12 months of the Closing Date
      • 1 million shares each if the share price equals or exceeds $12.50 for 20/30 trading days before the 36-month anniversary of Closing.
      • 1 million shares each if the share price equals or exceeds $15.00 for 20/30 trading days before the 36-month anniversary of Closing.

LOCK-UP

  • Company and Sponsor
    • Not yet entered into at this time.

NOTABLE CONDITIONS TO CLOSING

  • At the Closing, PowerUp having $5,000,000 in either remaining in the Trust Account or available from the concurrent consummation of a PIPE (after giving effect to the completion and payment of any redemptions, PowerUp’s unpaid expenses or Liabilities, the payment of an advisory fee owed to Sponsor, the repayment of certain Company Convertible Notes, and the repayment of the Working Capital Loans)
    • The minimum cash closing condition was reduced to $1.00 – LINK

NOTABLE CONDITIONS TO TERMINATION

  • By either PowerUp and Visiox if any of the conditions to Closing have not been satisfied or waived by May 31, 2024 (the “Outside Date”), provided that any breach or violation of any representation, warranty or covenant of the party seeking termination is not the cause of the failure of the Closing to occur by the Outside Date
    • The Outside Date was extended until June 30, 2024 – LINK

ADVISORS

  • Company
    • Nelson Mullins Riley & Scarborough LLP serves as legal counsel.
  • SPAC
    • Dykema Gossett PLLC serves as legal counsel.

SUBSEQUENT EVENT – 7/19/23 – LINK

  • The SPAC agreed to sell its Sponsor shares to SHIRAMA Associates.
    • The closing of the transactions contemplated in the Purchase Agreement is expected to take place on or before August 18, 2023, or on such other date as the parties agree in writing.

EXTENSION – 5/23/23 – LINK

  • The SPAC approved the extension from May 23, 2023 to May 23, 2024.
    • 26,946,271 shares were redeemed at the meeting for $10.55 per share.
    • No contribution will be made into the trust account.

SUBSEQUENT EVENT – 5/15/23 – LINK

  • The SPAC entered into a non-redemption agreement with several unaffiliated third parties in exchange for them agreeing not to redeem an aggregate of 1,500,000 shares
    • The Sponsor will transfer 750,000 Class B shares to the non-redeeming shareholders

SUBSEQUENT EVENT – 5/9/23 – LINK

  • The SPAC entered into a non-redemption agreement with several unaffiliated third parties in exchange for them agreeing not to redeem an aggregate of 750,000 shares
    • The Sponsor will transfer 375,000 Class B shares to the non-redeeming shareholders

SUBSEQUENT EVENT – 5/1/23 – LINK

  • The SPAC entered into a non-redemption agreement with several unaffiliated third parties in exchange for them agreeing not to redeem an aggregate of 150,000 shares
    • The Sponsor will transfer 75,000 Class B shares to the non-redeeming shareholders

MANAGEMENT & BOARD


Executive Officers

Surendra Ajjarapu, 53 [Appointed]
Director (Executive Chairman)

Suren Ajjarapu (age: 53) has served as Chairman of the Board, Chief Executive Officer and Secretary of TrXADE HEALTH, INC (Nasdaq: MEDS) a Delaware corporation, and its predecessor company since July 2010. He is also currently a director of Oceantech Acquisition I Corp., traded on Nasdaq under the symbol “OTECU”, serves as Chairman of the board of directors of Kernel Group Holdings, Inc., a special purpose acquisition company (NASDAQ: KRNL) (“KRNL”) (since December 2022) and Semper Paratus Acquisition Corporation, a special purpose acquisition company (NASDAQ: LGSTU). Beginning in 2021, Mr. Ajjarapu served as Chief Executive Officer and Chairman of Aesther Healthcare Acquisition Corp., a special purpose acquisition company that consummated its initial business combination in February 2023. Mr. Ajjarapu is currently serving as a director of the merged company, Ocean Biomedical, Inc. (NASDAQ: OCEA) (f.k.a Aesther Healthcare Acquisition Corp.). Since March 2018, Mr. Ajjarapu has served as Executive Chairman of the Board of Kano Energy Corp., a company involved in the development of renewable natural gas sites in the United States. Mr. Ajjarapu was a Founder and served as Chief Executive Officer and Chairman of the Board of Sansur Renewable Energy, Inc., a company involved in developing wind power sites in the Midwest of the United States, from March 2009 to December 2012. Mr. Ajjarapu was also a Founder, President and Director of Aemetis, Inc., a biofuels company (NASDAQ: AMTX), and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis, Inc., from January 2006 to March 2009. Mr. Ajjarapu was Co-Founder, Chief Operations Officer, and Director of Global Information Technology, Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India. Mr. Ajjarapu graduated from South Dakota State University with a M.S. in Environmental Engineering, and from the University of South Florida with an M.B.A., specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.


Howard Doss, 69 [Appointed]
Director (Executive Chairman)

Howard Doss (age: 69) is a seasoned chief financial officer and accountant. He currently serves as Chief Financial Officer of KRNL. And, beginning in 2021, he served as Chief Financial Officer of Aesther Healthcare Acquisition Corp., a special purpose acquisition company until it consummated its initial business combination in February 2023. He has also served as chief financial officer of TRxADE HEALTH, INC., an online marketplace for health traded on Nasdaq under the symbol “MEDS.” Mr. Doss has served in a variety of capacities with accounting and investment firms. He joined the staff of Seidman & Seidman (BDO Seidman, Dallas) in 1977 and in 1980 he joined the investment firm Van Kampen Investments, opening the firm’s southeast office in Tampa, Florida in 1982. He remained with the firm until 1996 when he joined Franklin Templeton. After working for the Principal Financial Group office in Tampa, Florida, Mr. Doss was City Executive for U.S. Trust in Sarasota, Florida, responsible for high net worth individuals. He retired from that position in 2009. He served as CFO and Director for Sansur Renewable Energy, an alternative energy development company, from 2010 to 2012. Mr. Doss has also served as President of STARadio Corp. since 2005. Mr. Doss is a member of the America Institute of CPA’s. He is a graduate of Illinois Wesleyan University.


Bruce Hack, 72 [Resigned]
Director (Executive Chairman)

He led one of the video game industry’s most successful companies and co-led market-leading firms in the broader media and technology space. Mr. Hack was director then chairman of Technicolor SA from 2010 to 2019. Prior, he was a principal in the creation of Activision Blizzard and served as the company’s vice chairman from 2008 to 2009. Mr. Hack was chief executive officer of Vivendi Games from 2004 to 2008, where he architected one of the largest turnarounds in video game history and launched Blizzard’s World of Warcraft, one of the decade’s defining online games. He was vice chairman of the Universal Music Group from 1998 to 2001 and chief financial officer of Universal Studios from 1995 to 1998. He joined The Seagram Company in 1982 after serving as an international trade negotiator at the U.S. Treasury in Washington, D.C. Amongst his roles at The Seagram Company were chief financial officer of Tropicana Products, Inc. and director of strategic planning. Mr. Hack is the founder and chief executive officer of BLH Venture, a provider of consulting and investment services to companies in the media and entertainment sectors. Mr. Hack is a director at Games for Change, a member of Endeavor Global, and on advisory councils for both the Hamilton Lugar School for Global and International Studies at Indiana University and the Cornell University College of Arts and Sciences. He earned a Bachelor of Arts degree from Cornell University and an M.B.A. from the University of Chicago. We believe Mr. Hack is well-qualified to serve as a member of our board of directors due to his extensive strategic, operations, financial and leadership experiences at both the company and board levels.


Jack Tretton, 60 [Resigned]
Chief Executive Officer and Director

Mr. Tretton, with a 35-year career in gaming, is one of the great leaders in the last 25 years of console video gaming. Mr. Tretton was at Sony Computer Entertainment America from 1995 to 2014, serving as president and chief executive officer from 2006 to 2014. Mr. Tretton helped establish the PlayStation brand as a worldwide leader in interactive entertainment. Mr Tretton received credits on over 200 titles at Sony, with an average of 74% gross IRR. Under his leadership, Sony’s in-house titles posted stronger sales trends versus the overall industry average, with an average outperformance of 42% for AAA releases. During his tenure, Sony’s global video game revenue grew from $1.9 billion in the fiscal year ending March 1995 to $11.6 billion in the fiscal year ending March 2015. Sony PlayStation outperformed the top competitors across several key dimensions in combined hardware and software revenues. In 2014, Mr Tretton founded Interactive Concepts LLC, a consulting firm that provides management, research, fundraising, and publishing services for over 30 different clients including Fortune 500 companies. In 2018, Mr Tretton founded Interactive Gaming Ventures. Prior to Sony, Mr. Tretton was General Manager at JVC Musical Industries from 1991 to 1995 and Vice President of Sales at Activision from 1986 to 1991. Mr. Tretton graduated from Providence College with a Bachelor of Science, Marketing.


Michael Olson, 43 [Resigned]
Chief Financial Officer

Mr. Olson is currently the chief financial officer of Version1, a multi-property esports organization. Previously, Mr. Olson was a managing director and senior equity research analyst at Piper Sandler (formerly Piper Jaffray & Co.). Mr. Olson spent 19 years at Piper Sandler from 2001 to 2020 covering the video game, internet and digital media sectors. Mr. Olson earned an undergraduate degree in Business (Finance, Investments and Banking) from the University of Wisconsin-Madison.


Gabriel Schillinger, 32 [Resigned]
President

Mr. Schillinger was founder and chief executive officer of Gamma Innovations, which created a distributed computing platform that was powered by almost a million gamers across the globe as of June 2019. Gamma Innovations partnered with Razer, a lifestyle brand for gamers, to launch Softminer in 2018. Mr. Schillinger led the sale of Gamma to Animoca Brands in 2019. Prior to Gamma, Mr. Schillinger founded BIM Networks in 2009, a mobile payments company that provides an alternative ACH platform for quick service retail merchants. Mr. Schillinger graduated from New York University.


Matthew Ball, 33 [Resigned]
Chief Strategy Officer

Mr. Ball is the managing partner of EpyllionCo, which operates a venture and corporate advisory arm and an early stage venture fund. Mr. Ball is also a venture partner at Makers Fund, and an advisor to start-ups including Genvid Technologies, The Athletic, and Parrot Analytics. Mr. Ball also co-produced “Rival Peak,” a cloud-native video game, which premiered on Facebook in December 2020 and accumulated hundreds of millions of watch-time. Mr. Ball is also a renowned theorist writing on the Metaverse. His essays have received praise from Mark Zuckerberg, Tencent Global PR, and have been covered by New York Times, The New Yorker, Wired, The Economist, and more. He is a co-founder of the Ball Metaverse Index, the Index behind the Roundhill Ball Metaverse ETF, which is listed on the New York Stock Exchange and is in the top 5% of U.S.-listed ETFs in terms of inflows in the second half of 2021, having launched June 30 2021. From 2016 to 2018, Mr. Ball served as head of strategy and planning for Amazon Studios, a global role that oversaw many major content investments for the studio. Prior to joining Amazon, Mr. Ball was a director at The Chernin Group’s Otter Media. Until 2015, Mr. Ball was also an executive at Accenture in its Corporate Strategy: Technology, Media, and Telecommunications practice. Mr. Ball is a graduate of Canada’s Ivey Business School.



Board of Directors

Michael L. Peterson, 51 [Appointed]
Director Nominee

Michael Peterson (age: 61) commenced serving as President, Chief Executive Officer and as a member of the Board of Directors of Lafayette Energy Corp. in April 2022. Beginning in September 2021, Mr. Peterson served as a member of the Board of Directors, Audit Committee (Chair), Compensation Committee and Nominating and Corporate Governance Committee of Aesther Healthcare Acquisition Corp. (Nasdaq: AEHA), a special purpose acquisition company, that consummated its initial business combination in February 2023. Mr. Peterson is currently serving as a director of the merged company, Ocean Biomedical, Inc. (Nasdaq: OCEA) (f.k.a Aesther Healthcare Acquisition Corp.). In addition, Mr. Peterson commenced serving as an independent director of Oceantech Acquisition I Corp., in March 2023, began serving as an independent director of KRNL in December 2022 and as an independent director of Semper Paratus Acquisition Corporation in June 2023. Mr. Peterson has served as the president of Nevo Motors, Inc. since December 2020, which was established to commercialize a range extender generator technology for the heavy-duty electric vehicle market but is currently non-operational. Since May 2022, Mr. Peterson has served as a member of the Board of Directors and as the Chairperson of the Audit Committee of Trio Petroleum Corp., an oil and gas exploration and development company which is in the process of going public. Since February 2021, Mr. Peterson has served on the board of directors and as the Chairman of the Audit Committee of Indonesia Energy Corporation Limited (NYSE American: INDO). Mr. Peterson previously served as the president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan from June 2018 to June 2021. Mr. Peterson served as an independent member of the Board of Directors of TRxADE HEALTH, INC (formerly Trxade Group, Inc.) from August 2016 to May 2021 (Nasdaq: MEDS). Mr. Peterson served as the Chief Executive Officer of PEDEVCO Corp. (NYSE American:PED), a public company engaged primarily in the acquisition, exploration, development and production of oil and natural gas shale plays in the US from May 2016 to May 2018. Mr. Peterson served as Chief Financial Officer of PEDEVCO between July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (PEDEVCO’s predecessor) from July 2012 to October 2014, and as PEDEVCO’s President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a director (from May 2006 to July 2012) of Aemetis, Inc. (formerly AE Biofuels Inc.), a Cupertino, California-based global advanced biofuels and renewable commodity chemicals company (NASDAQ:AMTX), and as Chairman and Chief Executive Officer of Nevo Energy, Inc. (NEVE) (formerly Solargen Energy, Inc.), a Cupertino, California-based developer of utility-scale solar farms which he helped form in December 2008 (from December 2008 to July 2012). From 2005 to 2006, Mr. Peterson served as a managing partner of American Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high-net-worth investors. From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs & Co. in a variety of positions and roles, including as a Vice President. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham Young University.


Donald G. Fell, 77 [Appointed]
Director Nominee

Donald G. Fell (age 77) brings along a wealth of experience in the field of economics and business to the Company. Mr. Fell served as an independent director of Aesther Healthcare Acquisition Corp., a special purpose acquisition company, from 2021 until it consummated its initial business combination in February 2023. Mr. Fell has served as an independent director of TRxADE HEALTH, INC (Nasdaq: MEDS) since January 2014, as well as a director of Trxade Nevada since December 2013. In addition, he commenced serving as an independent director of OTEC in March 2023. In addition, Mr. Fell commenced serving as an independent director of Oceantech Acquisition I Corp., in March 2023, began serving as an independent director of KRNL in December 2022 and as an independent director of Semper Paratus Acquisition Corporation in June 2023. He is presently Professor and Institute Director for the Davis, California-based Foundation for Teaching Economics and adjunct professor of economics for the University of Colorado, Colorado Springs. Mr. Fell held positions with the University of South Florida as a member of the Executive MBA faculty, Director of Executive and Professional Education and Senior Fellow of the Public Policy Institute from 1995 to 2012. Mr. Fell was also a visiting professor at the University of LaRochelle, France, and an adjunct professor of economics at both Illinois State University and The Ohio State University. Mr. Fell holds undergraduate and graduate degrees in economics from Indiana State University and his all but dissertation (ABD) in economics from Illinois State University. Through his work with the Foundation for Teaching Economics and the University of Colorado, Colorado Springs he has overseen graduate institutes on economic policy and environmental economics in 44 states, throughout Canada, the Islands and Eastern Europe.


Avinash Wadhwani, 55 [Appointed]
Director Nominee

Mr. Wadhwani (age: 55) is currently the Executive Vice President and Strategic Advisor of TransForm Solution Inc., a business process outsourcing (BPO) company that specializes in analytics, digital interventions, and operations management, a role he has served in since May 2023. From April 2009 to April 2020, Mr. Wadhwani held positions at Cognizant Technology Solutions (“Cognizant”), a multi billion dollar, IT services and consulting company, ending his tenure at Cognizant as Assoc. Director, Capital Markets & Investment Banking. Mr. Wadhwani served as Senior Manager, Business Development – Banking & Capital Markets at Headstrong (now Genpact (NYSE: G)) from 2003 to 2005 and as Assistant Vice President at Polaris Software Services from 1999 to 2002. In India, Mr. Wadhwani served as the Head of Institutional Equity Sales at Daewoo Finance (India) Ltd. from 1994 to 1999 and in product marketing and sales at Tata Consultancy Services from 1991 to 1994. Throughout his career, Mr. Wadhwani has negotiated and closed several multi-year, multi-million dollar global technology service deals across the financial services, retail and media & entertainment industries. He is the co-founder of a SaaS based blockchain startup, which he was instrumental in conceptualizing, architecting and building from the ground up. Mr. Wadhwani brings hands on experience working at startups, growth stage organizations, and Fortune 500 companies. He serves on the board of Semper Paratus Acquisition Corp (NASDAQ: LGST) and on the board of a U.S. based nonprofit, Quench and Nourish. Mr. Wadhwani earned a degree in Computer Science and a Masters in Marketing degree, both from the University of Mumbai. He holds an MBA (Executive) from the Columbia Business School in New York City.


Mayur Doshi, 61 [Appointed]
Director Nominee

Mr. Doshi (age: 61) is President and CEO of Alfagene Bioscience, Inc. He has successfully initiated several companies and for the last ten years has been the CEO of Apogee Pharma. He has over 20 years of experience in the global generic pharmaceutical market. He is a trained chemist and seasoned entrepreneur with extensive experience in active pharmaceutical ingredients. He has more than twenty years of Pharmaceutical and Bio-tech industry experience; entering the generic pharmaceutical industry in 1988. He is Chairman and Managing Director of Apogee Pharma, Inc., a major importer of APIs (Active Pharmaceutical Ingredients). He works closely with his clients assisting them in bringing new generic drugs to market, including Barr Pharmaceuticals, DuPont Pharmaceuticals, Sandoz, Wyeth and Watson. He is also a major investor in a generic pharmaceutical company and is the founder of, and primary investor in, AlfaGene. He worked and managed extensively in the Pharmaceutical industry and created a multimillion dollar company. Mr. Doshi also serves as a philanthropist for various organizations.


Peter Blacklow, 52 [Resigned]
Director Nominee

Mr. Blacklow is a general partner at Boston Seed Capital and co-founded the fund in 2010. Mr. Blacklow serves on the boards of Reggora, Alyce, QL Gaming Group, Beamable, and is co-chairman and co-founder of Drive by DraftKings. Mr. Blacklow served as executive vice president of digital at the Game Show Network from 2006 to 2013. Previously, Mr. Blacklow served as chief marketing officer for WorldWinner/FUN Technologies from 2003 to 2006. Prior to that, Mr. Blacklow was senior vice president of marketing at Monster.com from 1999-2003. Before Monster.com, Mr. Blacklow ran the global basketball business unit at Converse from 1995-1999. Mr. Blacklow received a Bachelor of Arts degree from Harvard University.


Anna Sweet, 39 [Resigned]
Director Nominee

Ms. Sweet has served as the chief executive officer of Bad Robot Games since 2020. Prior, Ms. Sweet worked at Caffeine, a live streaming company, as senior vice president of content and community from 2017 to 2019. Ms. Sweet was head of content and social VR at Facebook in 2017 and was head of developer strategy at Oculus from 2015 to 2016. Previously, Ms. Sweet was senior product and business development manager at Valve from 2009 to 2015, working on the team that developed the Steam platform, a leading video game distribution service. She began her career in the Xbox division of Microsoft, working on Xbox’s platform technologies from 2004 to 2007. In 2020, Ms. Sweet joined makers fund as a venture partner. Ms. Sweet earned a computer science degree from Rochester Institute of Technology.


Julie Uhrman, 47[Resigned]
Director Nominee

Ms. Uhrman is a founder, chief executive officer, and president of Angel City Football Club, the National Women’s Soccer League’s newest professional women’s soccer team launching in Los Angeles in 2022. Ms. Uhrman most recently was the president of media for PEI, a global media and lifestyle company, from 2018-2020, where she oversaw the company’s media offerings across all verticals. Previously, Ms. Uhrman served as executive vice president and general manager of Over-The-Top Ventures for Lionsgate, building and managing the company’s multiple streaming franchises, from 2016-2018. In 2013, Ms. Uhrman founded and was chief executive officer of OUYA, a pioneering android-based game console for the living room, which raised a record-breaking $8.6 million through Kickstarter and then went on to secure venture funding from Kleiner Perkins and Alibaba before selling to Razer in 2015. Ms. Uhrman has been named one of Adweek’s 2020 Most Powerful Women In Sports, one of the 100 Most Creative People in Business by Fast Company and one of the Creative 50 by Ad Age. Ms. Uhrman graduated from Washington University in St. Louis and received her MBA from UCLA Anderson School of Business.


Kyle Campbell, — [Appointed 5/16/22] [Resigned]
Director

Since May 2021, Mr. Campbell has served as a senior analyst at Greenhaven Road Capital, a long-term investment manager seeking to invest in opportunities off the beaten path, where he has gained extensive knowledge and experience with SPAC structures, incentives, and PIPE transactions. Mr. Campbell was formerly the Chief Financial Officer of a single-family office, a position he held from 2015 to 2019, where he oversaw all accounting, investment, and capital allocation decisions. Mr. Campbell holds a B.S. degree in Business from Bellevue University and a Master of Business Administration from the Columbia Business School.